An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer

BACKGROUND: Men with metastatic castration-resistant prostate cancer (mCRPC) are living longer, therefore optimizing health-related quality of life (HRQL), as well as survival outcomes, is important for optimal patient care. The aim of this study was to assess the HRQL in patients with mCRPC receivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiery-Vuillemin, A., Fizazi, K., Sartor, O., Oudard, S., Bury, D., Thangavelu, K., Ozatilgan, A., Poole, E.M., Eisenberger, M., de Bono, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980065/
https://www.ncbi.nlm.nih.gov/pubmed/33740734
http://dx.doi.org/10.1016/j.esmoop.2021.100089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980065/
https://www.ncbi.nlm.nih.gov/pubmed/33740734
http://dx.doi.org/10.1016/j.esmoop.2021.100089

Ejemplares similares